Home » Topics » BioWorld Science

BioWorld Science
RSS

Antiinflammatory imidazolyl compounds from Searle

May 20, 1997

Cerebrovascular selectivity and vasospasmolytic action of AJ-3941

May 20, 1997

Roche and Protein Design Labs report encouraging results from Zenapax trial

May 20, 1997

Safety, pharmacological, phase I and early phase II results for SM-10902

May 20, 1997

Aronex extends clinical trials with Nyotran

May 20, 1997

Phase I/II results for promising compound from BioTransplant and MedImmune

May 20, 1997

RPR's Azmacort now available in Brazil

May 20, 1997

HemaSure stops development of SteriPath

May 20, 1997

Positive phase II/III results for Cortecs' Macritonin

May 20, 1997

Ribi ImmunoChem offers licenses for cardioprotectant

May 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...